Clinical Trial Update: Taking AIM at Breast Cancer [NA]

View source ↗

Summary

Dana-Farber Cancer Institute's breast cancer trial (NCT04720209) is currently active but not recruiting, spanning stages I–III. No enrollment is currently ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer, Breast Cancer Stage I | NA | Status: ACTIVE_NOT_RECRUITING